Recital 38, Directive (EU) 1998/44

In forcesince 6 Jul 1998cited 3×

Whereas the operative part of this Directive should also include an illustrative list of inventions excluded from patentability so as to provide national courts and patent offices with a general guide to interpreting the reference to ordre public and morality; whereas this list obviously cannot presume to be exhaustive; whereas processes, the use of which offend against human dignity, such as processes to produce chimeras from germ cells or totipotent cells of humans and animals, are obviously also excluded from patentability;

  • Judgment of the Court (Grand Chamber) of 18 October 2011. Oliver Brüstle v Greenpeace eV.Decision

    To that effect, as the Court has already held, Article 5(1) of the Directive provides that the human body at the various stages of its formation and development cannot constitute a patentable invention. Additional security is offered by …

    18 Oct 2011 · 62010CJ0034

  • Opinion of Advocate General Cruz Villalón delivered on 17 July 2014. International Stem Cell Corporation v Comptroller General of Patents, DDecision

    Recitals 5, 16, 20, 21, 36 to 39, and 42 of the Directive read as follows: … differences exist in the legal protection of biotechnological inventions offered by the laws and practices of the different Member States; … such differences …

    17 Jul 2014 · 62013CC0364

  • Judgment of the Court (Grand Chamber), 18 December 2014. International Stem Cell Corporation v Comptroller General of Patents, Designs and TDecision

    Recitals 1 to 3, 16, 37 to 39, 42 and 43 in the preamble to Directive 98/44 are worded as follows: ‘(1) Whereas biotechnology and genetic engineering are playing an increasingly important role in a broad range of industries and the …

    18 Dec 2014 · 62013CJ0364